GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Trade Payables History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Trade Payables | ₹2,536 Cr | ₹2,000 Cr | ₹2,289 Cr | ₹2,238 Cr | ₹2,126 Cr |
What is the latest Trade Payables ratio of GLENMARK PHARMACEUTICALS ?
Year | Trade Payables |
---|---|
Mar2024 | ₹2,536 Cr |
Mar2023 | ₹2,000 Cr |
Mar2022 | ₹2,289 Cr |
Mar2021 | ₹2,238 Cr |
Mar2020 | ₹2,126 Cr |
How is Trade Payables of GLENMARK PHARMACEUTICALS Trending?
Years | Trade Payables | % Change | |
---|---|---|---|
Mar2024 | ₹2,536 Cr | 26.77 | |
Mar2023 | ₹2,000 Cr | -12.59 | |
Mar2022 | ₹2,289 Cr | 2.27 | |
Mar2021 | ₹2,238 Cr | 5.26 | |
Mar2020 | ₹2,126 Cr | - |
Compare Trade Payables of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹62,844.5 Cr | 22.5% | 32.4% | 60.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 22.5% |
32.4% |
60.4% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses